JP Morgan Maintains Neutral on Pfizer, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Neutral 52.1%

Neg 0% Neu 52.1% Pos 0%

JP Morgan analyst Chris Schott maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $28 to $30.

Comments

No comments yet. Be the first!